This inventor holds 1 USPTO granted patent. Top assignee: Baylor College of Medicine. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: The Innovations of Frederick B. Hollinger
Introduction
Frederick B. Hollinger is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of immunology, particularly in the development of compositions aimed at inducing an immunological response. His work has implications for the treatment and prevention of hepatitis B.
Latest Patents
Hollinger holds a patent for a cyclic peptide and method of use for inducing an immunological response. This patent describes a composition designed to elicit the production of antibodies to the hepatitis B surface antigen. The method also includes a technique for neutralizing the infectivity of the hepatitis B virus. The cyclic polypeptide is prepared with a disulfide bond in a hydrophilic region, specifically residues 117-137 or 122-137, and features an amino acid sequence that is unique from that associated with the native 25,000 molecular weight polypeptide derived from hepatitis B surface antigen. He has 1 patent to his name.
Career Highlights
Hollinger is affiliated with the Baylor College of Medicine, where he continues to advance research in immunology. His work has been instrumental in understanding how to combat hepatitis B, a virus that poses significant health risks worldwide.
Collaborations
Some of his notable coworkers include Gordon R. Dreesman and Darrell L. Peterson. Their collaborative efforts have contributed to the advancements in the field of immunology and the development of innovative solutions for viral infections.
Conclusion
Frederick B. Hollinger's contributions to immunology through his innovative patent highlight the importance of research in combating viral diseases. His work at Baylor College of Medicine continues to pave the way for future advancements in medical science.